PPD’s bioanalytical labs in Middleton, Wis., and Richmond, Va., provide accurate, high quality results across all phases of drug development and commercialization.  We offer bioanalytical services such as comprehensive, state-of-the-art assay development; transfer, validation and sample analysis in multiple biological species and matrices; and metabolite identification. The labs have expertise in many proven validated methods (Adobe Acrobat file, 258 KB) to quantitatively measure all types of compounds using LC/MS/MS, HPLC and immunochemistry.

PPD’s bioanalytical labs offer substantial capacity and expertise in the highly sensitive and precise technique of liquid chromatography/mass spectrometry (LC/MS/MS) bioanalysis.

PPD provides comprehensive immunochemistry services, including cell-based and ligand-binding assay services, for compounds in development with special emphasis on monoclonal antibody drugs, protein drugs, protein drug conjugates and peptides.

Our labs also provide biomarker measurement services that can be designed to meet clients’ needs.

Learn more by viewing our online bioanalytical lab tour or visiting the state-of-the-art technology page.

On-Site Quality Assurance (QA) Department

Our independent quality assurance (QA) department ensures adherence to analytical methods, standard operating procedures (SOPs) and GLP regulatory obligations and guidelines. The team of regulatory experts at PPD helps expedite the approval process because of its in-depth knowledge of FDA bioanalytical guidelines, requirements and evolving expectations through extensive interaction with the FDA during 56 audits or inspections during the last 25 years.